Tagged with M

Ireland Bill Doherty, MD of Cook Ireland and EVP of Cook Group Europe, one of the largest private medical device companies in the world, discusses his main priorities at the moment, the impact of the Group’s transformation on EMEA, his thoughts on the successful evolution of the Irish MedTech sector, and…

Philippines Enrique Ona, the former Secretary of Health in the Philippines, discusses his tenure as secretary of state, the effects of revenues from a “sin tax” on expanding universal healthcare to all Filipino citizens, as well as some of the challenges being faced in fully realizing this goal. He also discusses…

Luxembourg Sound infrastructure, a prime location in the heart of Europe, government support, and an unwavering focus on quality are all helping make the tiny principality of Luxembourg a serious player in global healthcare logistics. “Some high ranked senior logistics executives from pharma companies have commented that [the Luxair Cargo Healthcare &…

Philippines Bert van Dierendonck and Alec van Dierendonck, Founder and Country Manager, as well as father and son, discuss Euro Generics’ unique history in the country and their road to becoming one of the fastest growing pharmaceutical companies in the Philippines. They also discuss their strategies for staying ahead of market…

Greece With extensive experience in the field of health economics, IOBE’s Head of the Health Economics Observatory, Thanos Athanasiadis, discusses the background of the organization, the state of the pharmaceutical market in Greece, and the existing challenges and opportunities in the country. To begin, could you please give an overview of…

Taiwan Grace Yeh, Founder, President, and CEO of PharmaEngine, one of the most eye-catching success stories to recently emerge from Taiwan’s maturing biopharmaceutical sector, documents the main success factors that have allowed PharmaEngine to become the first Taiwan-based company to receive FDA approval for a locally-developed oncology treatment, as well as…

Ireland Donal O’Callaghan, founder and CEO of Callaghan Engineering, an Irish engineering and construction firm, tells us what motivated him to break into the pharma market in 1990, the changes in the industry he has seen, and his ambition to position Callaghan Engineering as an engineering house of choice. You founded…

Singapore In an exclusive interview with Leslie Chua, the General Manager of the Solutions Division at Hitachi Medical Systems, he elaborates on how the division is building on the synergies of all the business units in order to provide healthcare solutions and reach a broader market in the APAC region. As…

Switzerland An expert in the implementation of Swiss federal laws within Switzerland’s constituent cantons, Giovan Maria Zanini discusses the evolution of Swiss pharma regulatory framework and efforts to strengthen and protect the country’s world leading innovation environment.  Dr. Zanini, you have been described as “the expert in the cantonal implementation of…

Taiwan Du-Shieng Chien, President & CEO of TaiRx, a Taiwan-based biopharmaceutical company focused on unmet medical needs, provides insights into the recent development of CVM 1118, a revolutionary cancer treatment targeting breakthrough mechanisms to tackle tumor development and the first drug of its kind to have already started clinical trials in…

Singapore DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the value chain where they can drive the most value for healthcare companies. He also comments on the strategic importance of a…

Ireland Frederic Secail, General Manager of Servier’s second strategic and international production facility within Servier Industry, located in Arklow, Ireland, outlines his ambitious transformation program, Arklow 2020, to anticipate and prepare the site for the future. You have been GM of Servier’s Arklow facility since 2013. What was the mandate given…